Delayed myelination in a mouse model of fragile X syndrome

Human Molecular Genetics

Volumn 22, Issue 19, 2013, Pages 3920-3930

  Pacey, Laura K K ^a   Xuan, Ingrid C Y ^a   Guan, Sihui ^a   Sussman, Dafna ^c   Henkelman, R Mark ^c   Chen, Yan ^b   Thomsen, Christian ^d   Hampson, David R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Lundbeck Research USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; GADOLINIUM PENTETATE; MYELIN BASIC PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; CELL FUNCTION; CELL MATURATION; CEREBELLUM; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; ELECTRON MICROSCOPY; FRAGILE X SYNDROME; KNOCKOUT MOUSE; MOUSE; MYELIN SHEATH; MYELINATION; NERVE FIBER; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; THICKNESS; WHITE MATTER; WILD TYPE;

MUS;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; ANIMALS, NEWBORN; CEREBELLUM; DISEASE MODELS, ANIMAL; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN SHEATH; NEURONS; OLIGODENDROGLIA;

EID: 84888781767     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt246     Document Type: Article

References (62)

1. Darnell, J.C., Van Driesche, S.J., Zhang, C., Hung, K.Y., Mele, A., Fraser, C.E., Stone, E.F., Chen, C., Fak, J.J., Chi, S.W. et al. (2011) FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell, 146, 247-261.
2. Bassell, G.J. and Warren, S.T. (2008) Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron, 60, 201-214.
3. Rooms, L. and Kooy, R.F. (2011) Advances in understanding fragile X syndrome and related disorders. Curr. Opin. Pediatr., 23, 601-606.
4. Hampson, D.R., Gholizadeh, S. and Pacey, L.K. (2012) Pathways to drug development for autism spectrum disorders. Clin. Pharmacol. Ther., 91, 189-200.
5. Mostofsky, S.H., Mazzocco, M.M., Aakalu, G., Warsofsky, I.S., Denckla, M.B. and Reiss, A.L. (1998) Decreased cerebellar posterior vermis size in 3928 Human Molecular Genetics, 2013, Vol. 22, No. 19 fragile X syndrome: correlation with neurocognitive performance. Neurology, 50, 121-130.
6. Hoeft, F., Carter, J.C., Lightbody, A.A., Cody, H.H., Piven, J. and Reiss, A.L. (2010) Region-specific alterations in brain development in one-to three-year-old boys with fragile X syndrome. Proc. Natl Acad. Sci. USA, 107, 9335-9339.
7. Greco, C.M., Navarro, C.S., Hunsaker, M.R., Maezawa, I., Shuler, J.F., Tassone, F., Delany, M., Au, J.W., Berman, R.F., Jin, L.W. et al. (2011) Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol. Autism, 2, 2.
8. Kaufmann, W.E., Cooper, K.L., Mostofsky, S.H., Capone, G.T., Kates, W.R., Newschaffer, C.J., Bukelis, I., Stump, M.H., Jann, A.E. and Lanham, D.C. (2003) Specificity of cerebellar vermian abnormalities in autism: a quantitative magnetic resonance imaging study. J. Child Neurol., 18, 463-470.
9. Whitney, E.R., Kemper, T.L., Bauman, M.L., Rosene, D.L. and Blatt, G.J. (2008) Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum, 7, 406-416.
10. Schumann, C.M. and Nordahl, C.W. (2011) Bridging the gap between MRI and postmortem research in autism. Brain Res., 1380, 175-186.
11. Ellegood, J., Pacey, L.K., Hampson, D.R., Lerch, J.P. and Henkelman, R.M. (2010) Anatomical phenotyping in a mouse model of fragile X syndrome with magnetic resonance imaging. Neuroimage, 53, 1023-1029.
12. Tsai, P.T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A.R., Leech, J.M., Steinberg, J., Crawley, J.N., Regehr, W.G. and Sahin, M. (2012) Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature, 488, 647-651.
13. Reith, R.M., McKenna, J., Wu, H., Hashmi, S.S., Cho, S.H., Dash, P.K. and Gambello, M.J. (2013) Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Neurobiol. Dis., 51, 93-103.
14. Pacey, L.K. and Doering, L.C. (2007) Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome. Glia, 55, 1601-1609.
15. Higashimori, H., Morel, L., Huth, J., Lindemann, L., Dulla, C., Taylor, A., Freeman,M. and Yang, Y. (2013) Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse. Hum. Mol. Genet., 22, 2041-2054.
16. Wang, H., Ku, L., Osterhout, D.J., Li, W., Ahmadian, A., Liang, Z. and Feng, Y. (2004) Developmentally-programmed FMRP expression in oligodendrocytes: a potential role of FMRP in regulating translation in oligodendroglia progenitors. Hum. Mol. Genet., 13, 79-89.
17. Callan, M.A., Clements, N., Ahrendt, N. and Zarnescu, D.C. (2012) Fragile X Protein is required for inhibition of insulin signaling and regulates glial-dependent neuroblast reactivation in the developing brain. Brain Res., 1462, 151-161.
18. Barnea-Goraly, N., Eliez, S., Hedeus, M., Menon, V., White, C.D., Moseley, M. and Reiss, A.L. (2003) White matter tract alterations in fragile X syndrome: preliminary evidence from diffusion tensor imaging. Am. J. Med. Genet. B Neuropsychiatr. Genet., 118B, 81-88.
19. Haas, B.W., Barnea-Goraly, N., Lightbody, A.A., Patnaik, S.S., Hoeft, F., Hazlett, H., Piven, J. and Reiss, A.L. (2009) Early white-matter abnormalities of the ventral frontostriatal pathway in fragile X syndrome. Dev. Med. Child Neurol., 51, 593-599.
20. Groen, W.B., Buitelaar, J.K., van der Gaag, R.J. and Zwiers, M.P. (2011) Pervasive microstructural abnormalities in autism: a DTI study. J. Psychiatry Neurosci., 36, 32-40.
21. Singh, K., Gaur, P. and Prasad, S. (2007) Fragile x mental retardation (Fmr-1) gene expression is down regulated in brain of mice during aging. Mol. Biol. Rep., 34, 173-181.
22. Alger, J.R. (2012) The diffusion tensor imaging toolbox. J. Neurosci., 32, 7418-7428.
23. Fitzner, D., Schneider, A., Kippert, A., Mobius, W., Willig, K.I., Hell, S.W., Bunt, G., Gaus, K. and Simons, M. (2006) Myelin basic protein-dependent plasma membrane reorganization in the formation of myelin. EMBO J., 25, 5037-5048.
24. Brady, S.T., Witt, A.S., Kirkpatrick, L.L., de Waegh, S.M., Readhead, C., Tu, P.H. and Lee, V.M. (1999) Formation of compact myelin is required for maturation of the axonal cytoskeleton. J. Neurosci., 19, 7278-7288.
25. Polito, A. and Reynolds, R. (2005) NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J. Anat., 207, 707-716.
26. Kucharova, K. and Stallcup, W.B. (2010) The NG2 proteoglycan promotes oligodendrocyte progenitor proliferation and developmental myelination. Neuroscience, 166, 185-194.
27. Stallcup, W.B. (2002) The NG2 proteoglycan: past insights and future prospects. J. Neurocytol., 31, 423-435.
28. Foran, D.R. and Peterson, A.C. (1992) Myelin acquisition in the central nervous system of the mouse revealed by an MBP-Lac Z transgene. J. Neurosci., 12, 4890-4897.
29. Hagerman, R., Hoem, G. and Hagerman, P. (2010) Fragile X and autism: intertwined at the molecular level leading to targeted treatments. Mol. Autism, 1, 12.
30. Rosenberg, S.S., Kelland, E.E., Tokar, E., De la Torre, A.R. and Chan, J.R. (2008) The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation. Proc. Natl Acad. Sci. USA, 105, 14662-14667.
31. Simons, M. and Trajkovic, K. (2006) Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis. J. Cell Sci., 119, 4381-4389.
32. Trapp, B.D. and Kidd, G.J. (2000) Axo-glial septate junctions. The maestro of nodal formation and myelination? J. Cell Biol., 150, F97-F100.
33. Voyvodic, J.T. (1989) Target size regulates calibre and myelination of sympathetic axons. Nature, 342, 430-433.
34. Berry-Kravis, E.M., Hessl, D., Rathmell, B., Zarevics, P., Cherubini, M., Walton-Bowen, K., Mu, Y., Nguyen, D.V., Gonzalez-Heydrich, J., Wang, P.P. et al. (2012) Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci. Transl. Med., 4, 152ra127.
35. Michalon, A., Sidorov, M., Ballard, T.M., Ozmen, L., Spooren, W., Wettstein, J.G., Jaeschke, G., Bear, M.F. and Lindemann, L. (2012) Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice. Neuron, 74, 49-56.
36. Luyt, K., Varadi, A., Durant, C.F. and Molnar, E. (2006) Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J. Neurochem., 99, 641-656.
37. Luyt, K., Slade, T.P., Dorward, J.J., Durant, C.F., Wu, Y., Shigemoto, R., Mundell, S.J., Varadi, A. and Molnar, E. (2007) Developing oligodendrocytes express functional GABA(B) receptors that stimulate cell proliferation and migration. J. Neurochem., 100, 822-840.
38. Pacey, L.K., Heximer, S.P. and Hampson, D.R. (2009) Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragileXknockout mice to audiogenic seizures. Mol. Pharmacol., 76, 18-24.
39. Henderson, C., Wijetunge, L., Kinoshita, M.N., Shumway, M., Hammond, R.S., Postma, F.R., Brynczka, C., Rush, R., Thomas, A., Paylor, R. et al. (2012) Reversal of disease-related pathologies in the fragileXmouse model by selective activation of GABA(B) receptors with arbaclofen. Sci. Transl. Med., 4, 152ra128.
40. Harauz, G. and Boggs, J.M. (2013) Myelinmanagement by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms. J. Neurochem., 125, 334-361.
41. Li, Z., Zhang, Y., Li, D. and Feng, Y. (2000) Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNA-binding proteins. J. Neurosci., 20, 4944-4953.
42. Zhang, Y. and Feng, Y. (2001) Distinct molecular mechanisms lead to diminished myelin basic protein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in qk(v) dysmyelination. J. Neurochem., 77, 165-172.
43. Zearfoss, N.R., Farley, B.M. and Ryder, S.P. (2008) Post-transcriptional regulation of myelin formation. Biochim. Biophys. Acta, 1779, 486-494.
44. Ascano, M., Mukherjee, N., Bandaru, P., Miller, J.B., Nusbaum, J.D., Corcoran, D.L., Langlois, C., Munschauer, M., Dewell, S., Hafner, M. et al. (2012) FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature, 492, 382-386.
45. Gravel, M., Robert, F., Kottis, V., Gallouzi, I.E., Pelletier, J. and Braun, P.E. (2009) 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: a novel RNA-binding protein that inhibits protein synthesis. J. Neurosci. Res., 87, 1069-1079.
46. Emery, B. (2010) Regulation of oligodendrocyte differentiation and myelination. Science, 330, 779-782.
47. Gallo, V., Zhou, J.M., McBain, C.J., Wright, P., Knutson, P.L. and Armstrong, R.C. (1996) Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J. Neurosci., 16, 2659-2670.
48. Gross, C., Yao, X., Pong, D.L., Jeromin, A. and Bassell, G.J. (2011) Fragile x mental retardation protein regulates protein expression and mRNA translation of the potassium channel kv4.2. J. Neurosci., 31, 5693-5698.
49. Olmos-Serrano, J.L., Paluszkiewicz, S.M., Martin, B.S., Kaufmann, W.E., Corbin, J.G. and Huntsman, M.M. (2010) Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J. Neurosci., 30, 9929-9938.
50. Cruz-Martin, A., Crespo, M. and Portera-Cailliau, C. (2012) Glutamate induces the elongation of early dendritic protrusions via mGluRsin wild type mice, but not in fragile X mice. PLoS. One., 7, e32446.
51. Till, S.M., Wijetunge, L.S., Seidel, V.G., Harlow, E., Wright, A.K., Bagni, C., Contractor, A., Gillingwater, T.H. and Kind, P.C. (2012) Altered maturation of the primary somatosensory cortex in a mouse model of fragile X syndrome. Hum. Mol. Genet., 21, 2143-2156.
52. Fields, R.D. (2008) White matter matters. Sci. Am., 298, 42-49.
53. Makinodan, M., Tatsumi, K., Manabe, T., Yamauchi, T., Makinodan, E., Matsuyoshi, H., Shimoda, S., Noriyama, Y., Kishimoto, T. and Wanaka, A. (2008) Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J. Neurosci. Res., 86, 2190-2200.
54. Malkova,N.V.,Yu, C.Z.,Hsiao,E.Y.,Moore, M.J. and Patterson, P.H. (2012) Maternal immune activation yields offspring displayingmouse versions of the three core symptoms of autism. Brain Behav. Immun., 26, 607-616.
55. Rana, S.A., Aavani, T. and Pittman, Q.J. (2012) Sex effects on neurodevelopmental outcomes of innate immune activation during prenatal and neonatal life. Horm. Behav., 62, 228-236.
56. Steele, C.J., Bailey, J.A., Zatorre, R.J. and Penhune, V.B. (2013) Early musical training and white-matter plasticity in the corpus callosum: evidence for a sensitive period. J. Neurosci., 33, 1282-1290.
57. Makinodan, M., Rosen, K.M., Ito, S. and Corfas, G. (2012) A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science, 337, 1357-1360.
58. Miller, D.J., Duka, T., Stimpson, C.D., Schapiro, S.J., Baze, W.B., McArthur, M.J., Fobbs, A.J., Sousa, A.M., Sestan, N., Wildman, D.E. et al. (2012) Prolonged myelination in human neocortical evolution. Proc. Natl Acad. Sci. USA, 109, 16480-16485.
59. Gabel, L.A.,Won,S., Kawai, H.,McKinney, M., Tartakoff, A.M.and Fallon, J.R. (2004) Visual experience regulates transient expression and dendritic localization of fragileXmental retardation protein. J. Neurosci., 24, 10579-10583.
60. Paxinos, G., Halliday, G.M., Watson, C., Koucherov, Y. and Wang, H. (2007) Atlas of the Developing Mouse Brain at E17.5, P0 and P6. Elsevier, New York, NY.
61. Williams, R.W. and Chalupa, L.M. (1983)Ananalysis of axon caliber within the optic nerve of the cat: evidence of size groupings and regional organization. J. Neurosci., 3, 1554-1564.
62. Adusei, D.C., Pacey, L.K., Chen, D. and Hampson, D.R. (2010) Early developmental alterations in GABAergic protein expression in fragile X knockout mice. Neuropharmacology, 59, 167-171.